Guide · Updated November 2026

Why Is Ozempic So Much Cheaper Outside the US?

In 2023 the Peterson-KFF Health System Tracker found Ozempic's US list price was over five times Japan's. US cash prices have dropped a lot since then, but a September 2026 Peterson-KFF analysis still found the US cash price for an Ozempic pen was the highest among the peer countries it compared. Here's what the gap looks like now, why it exists, and why importing the drug yourself is riskier than it sounds.

I hear a version of “why don’t I just order it from Canada” constantly. The price gap is real enough that the question makes sense. The answer is more complicated than a shipping label.

The price gap, by the numbers

There are two different comparisons worth knowing. The first is the 2023 list-price study most articles still quote. The second is the 2026 comparison against the new US cash prices.

2023 list prices. The Peterson-KFF Health System Tracker’s 2023 analysis put one month of Ozempic at $936 in the US versus $169 in Japan, and said the US price was about ten times the price in Sweden, the UK, Australia and France. It put a month of Wegovy at $1,349 in the US versus $328 in Germany and $296 in the Netherlands. These were list prices before rebates, converted at June 2023 exchange rates.

2026 cash prices. A September 2026 Peterson-KFF analysis of TrumpRx prices compared US cash prices with publicly listed prices in 11 peer countries:

Drug	US cash price (TrumpRx)	Peer-country comparison
Ozempic pen	$349	Highest of all countries compared. Next highest was $190.
Wegovy pen	$349	Only Germany was higher, at $427
Zepbound KwikPen, maintenance doses	$449	Highest of all countries compared. Next highest was $423.

Peer prices were collected in August 2026 and not adjusted for cost of living. Some are government reimbursement prices and some, like Germany’s, are what a consumer pays at a pharmacy.

So the gap has narrowed a lot for cash buyers, and for Wegovy the US cash price is no longer the highest. For Ozempic it is still close to double the next most expensive country.

Why the gap exists

It isn’t that Novo Nordisk and Eli Lilly manufacture a different, cheaper product for other countries. The molecule is identical. What’s different is who sets the price.

Countries like the UK, Germany, Japan, Australia and France run national health systems (or systems with a dominant national payer) that negotiate drug prices directly with manufacturers, often using formal health-technology assessments to decide what a drug’s benefit is worth before agreeing to pay for it. If a manufacturer wants access to that country’s market, it accepts the negotiated price or doesn’t sell there.

The US has no equivalent. Drug manufacturers set their own US list price, and the fragmented mix of private insurers, PBMs and government programs each negotiate separately, with none holding the kind of single-payer bargaining power a national health system has. For the mechanics of what happens instead, our guide on GLP-1 pricing covers the patent, manufacturing and PBM-rebate side of the US number specifically.

This isn’t unique to GLP-1s. It’s the same pattern seen across many brand-name drugs sold in the US versus peer nations.

Want the current US cash-pay numbers instead?

See Current Cheapest US Prices →

Can you just buy it from Canada?

This is where most articles on this topic stop short. Here’s the legal picture.

The FDA says that in most circumstances it is illegal for individuals to import drugs into the US for personal use. FDA staff may use discretion when several conditions all apply: the drug treats a serious condition for which effective treatment may not be available in the US, it isn’t promoted to US residents, it doesn’t pose an unreasonable risk, the quantity is generally no more than a three-month supply, and the person either names the US-licensed doctor managing their care or shows the drug continues treatment started abroad.

The catch for GLP-1s: Ozempic, Wegovy, Mounjaro and Zepbound are all FDA-approved and sold in the US. That works against the “treatment not available here” condition. Semaglutide is regulated as a drug, not a biologic. Drugs@FDA lists Ozempic under New Drug Application 209637. So the long-tolerated pattern people describe for insulin doesn’t automatically carry over. This is a gray area, not a safe harbor, and enforcement practice can change.

There’s also a supply problem. In 2023, British Columbia’s health minister said the province would change pharmacy rules to stop drug exports to the US after Ozempic sales to Americans raised shortage concerns. A Canadian pharmacy that will ship you a real product, at a real discount, consistently, is a narrower list than the ads suggest. Products bought abroad may also not be the US-approved version, which is one of the FDA’s main stated concerns.

Compare legitimate US options before looking abroad

Browse the Provider Directory →

What closes the gap domestically

The honest answer for most US patients isn’t importation. It’s using the channels already built to bring the US price down:

Manufacturer self-pay programs. As of Nov 4, 2026, NovoCare lists Wegovy pens at $199 for each of the first two starter fills for eligible new patients, then $349 for standard doses, with Wegovy tablets from $149. Lilly lists Zepbound KwikPen or vial at $299 for 2.5 mg, $399 for 5 mg and $449 for higher doses under a refill offer. NovoCare lists Ozempic at $349 a month for 0.25 mg to 1 mg and $499 for 2 mg after the new-patient offer. See our savings guide for the full terms.
Manufacturer savings cards, if you have commercial insurance that covers the drug. These advertise copays as low as $25, but each has a monthly cap. Wegovy, Ozempic and Zepbound single-dose pen cards cap at $100 a month.
The Medicare GLP-1 Bridge, if you’re an eligible Medicare Part D beneficiary. CMS says it runs from July 1, 2026 to December 31, 2027 with a $50 copay. Our Medicare coverage guide covers eligibility.
Patient assistance programs, if you’re uninsured and income-qualified for the specific drug’s program.

None of these match the lowest prices abroad for Ozempic. They do get most patients far below the old $936 to $1,349 list prices, without the legal and supply uncertainty of importing.

Bottom Line

Ozempic and Wegovy cost more in the US than in most peer countries because those countries negotiate or set drug prices nationally and the US does not. The drug itself is the same. US cash prices fell sharply in 2026, and Wegovy’s US cash price is now below Germany’s listed price, but Ozempic’s US cash price was still the highest in the September 2026 Peterson-KFF comparison. Importing from Canada sits in a legal gray area, and Canadian provinces have pushed back on exports. For most US patients, the realistic path to a lower price is a domestic cash-pay or assistance program, not a cross-border workaround.

FAQ

Why is Ozempic so much cheaper in Canada, the UK, or Japan?

Those countries negotiate or directly set drug prices through national health systems before a manufacturer can sell there. The US has no equivalent single-payer negotiation, so manufacturers set the US list price on their own. The drug itself is identical.

Is it legal to buy Ozempic or Wegovy from a Canadian pharmacy?

The FDA says personal importation of drugs is illegal in most circumstances. It may use discretion for a small personal supply when effective treatment isn’t available in the US, but GLP-1s are approved and sold here, so that condition is hard to meet. This is not a guaranteed safe harbor.

How much cheaper is Ozempic in other countries, exactly?

In the 2023 Peterson-KFF list-price study, Ozempic’s US list price ($936) was over five times Japan’s ($169). In the September 2026 Peterson-KFF comparison, the US cash price of $349 for an Ozempic pen was the highest of the countries compared, and the next highest was $190. Exact figures shift with exchange rates and each country’s own updates.

Can I get in trouble for importing GLP-1 medication for personal use?

Federal law generally prohibits it, though the FDA has discretion over small personal-use quantities in limited situations. Because GLP-1s are available in the US, that discretion is less likely to fit. Provincial export limits in Canada add a separate supply risk.

What’s the fastest legitimate way to lower my GLP-1 cost in the US?

Check the manufacturer’s self-pay program (NovoCare or LillyDirect) and a manufacturer savings card if you have commercial insurance that covers the drug. Compare the price at your actual dose, not just the starter price.

Guides:

Compare: All Providers · All Guides

What we checked

This AI-assisted public-source desk check reviewed the 2023 and September 2026 Peterson-KFF price comparisons, the FDA personal importation page, the Drugs@FDA record for Ozempic, NovoCare and Lilly self-pay pages, the CMS Medicare GLP-1 Bridge page and Canadian news coverage of British Columbia’s export rules on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.